Trials / Conditions / Rubeosis Iridis
Rubeosis Iridis
4 registered clinical trials studyying Rubeosis Iridis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis NCT02641457 | Instituto de Olhos de Goiania | Phase 3 |
| Completed | Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery NCT01069341 | Bhagat, Neelakshi, M.D., M.P.H. | Phase 1 |
| Completed | Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Ma NCT00470977 | Manhattan Eye, Ear & Throat Hospital | Phase 1 / Phase 2 |
| Completed | Intraocular Bevacizumab (Avastin) for Rubeosis Iridis NCT00557232 | Instituto de Olhos de Goiania | Phase 4 |